SION - Sionna Therapeutics, Inc.
35.93
1.370 3.813%
Share volume: 310,437
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$34.56
1.37
0.04%
View ratios
| Fiscal Date | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|
| Fiscal Quarter | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-12-2025 | 11-05-2025 | 03-02-2026 | |
| Cash flow financing | 202.389 M | 1.974 M | 1.659 M | |
| Other financing cash flows | 0.000 | 1.974 M | 1.659 M | |
| Cash flow | 44.907 M | 9.846 M | 7.621 M | |
| Net income | -16.482 M | -20.278 M | -20.440 M | |
| Depreciation | 159.000 K | 189.000 K | 152.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -141.194 M | 23.102 M | 22.588 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 86.000 K | 87.000 K | 204.000 K | |
| Cash Change | 44.907 M | 9.846 M | 7.621 M |